PLoS ONE (Jan 2018)
Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0184550.].